This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Armin Braun: Innovator in Therapeutical Composition
Introduction
Armin Braun is a notable inventor based in Isernhagen, Germany. He has made significant contributions to the field of therapeutical compositions, particularly in the treatment of diseases using dendritic cells. His innovative approach has led to the development of a unique method that enhances the efficacy of these cells in medical applications.
Latest Patents
Armin Braun holds a patent for a therapeutical composition containing dendritic cells. The patent describes a method for preparing a therapeutical composition that involves treating dendritic cells with a combination of at least one interferon gamma receptor agonist and at least one toll-like receptor 2 and/or TLR 6 agonist. This innovative method aims to utilize pretreated dendritic cells for the treatment of various diseases and disorders.
Career Highlights
Armin Braun is associated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he has been instrumental in advancing research in immunotherapy. His work focuses on the intersection of immunology and therapeutic applications, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, Armin has collaborated with esteemed colleagues such as Peter Muhlradt and Norbert Krug. These partnerships have fostered a collaborative environment that enhances research and development in the field of therapeutical compositions.
Conclusion
Armin Braun's contributions to the field of therapeutical compositions highlight his innovative spirit and dedication to advancing medical science. His patent on dendritic cell treatment represents a significant step forward in the fight against various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile